Design Therapeutics, Inc. (DSGN)
NASDAQ·Healthcare·Biotechnology
$12.90
+0.66%
Mkt Cap $772.75M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$15.67
Range $14.00 – $18.00
Implied Upside
+21.5%
Consensus $15.67 vs current $12.90
NASDAQ·Healthcare·Biotechnology
$12.90
+0.66%
Mkt Cap $772.75M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$15.67
Range $14.00 – $18.00
+21.5%
Consensus $15.67 vs current $12.90